[Organic Panic]

Well then we better give them billions of dollars and force every one to take it regardless.

[Signalman]

Monoclonal antibodies work. Are they still being used?

[ransomnote]

For the two Covid drugs, which are under an Emergency Use Authorization, the drug companies say that the drugs are new and so not all side-effects are known, and they don't show the list of known side effects - you have to ask your doctor for those. Wonder if your doctor will tell you...

The brand name is Lagevrio.

~~~~~~~~~~~~~~~~

What Are Side Effects of Lagevrio?

Lagevrio may cause serious side effects including:

• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• dizziness

Side effects of Lagevrio include:

• diarrhea,
• nausea, and
• dizziness.

Get medical help right away, if you have any of the symptoms listed above.

Lagevrio is still being studied, so it is possible all of the risks are not known at this time.

• Seek medical care or call 911 at once if you have the following serious side effects:
• Serious eye symptoms such as sudden vision loss, blurred vision,tunnel vision,eye painor swelling, or seeing halos around lights;
• Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheartedness, or passing out;

Severe headache,confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

https://www.rxlist.com/lagevrio-side-effects-drug-center.htm

[Celerity]

Merck is late in their payments to the cpp.

So now all the media will publish this.

Brought to you by pfizer.

[Grampa Dave]

Merck’s Covid-19 Pill Does Not Cut Hospitalisation, Death Rates in Many Vaccinated Adults: Study
AsiaOne ^ | DECEMBER 22, 2022

3 minute read December 22, 20223:37 PM PSTLast Updated 20 hours ago

Merck’s COVID pill does not cut hospitalisation, death rates in many vaccinated adults - study
By Natalie Grover

LONDON, Dec 22 (Reuters) - Merck & Co Inc’s (MRK.N) COVID antiviral molnupiravir speeds up recovery but does not reduce the hospitalisation or death rate in higher-risk vaccinated adults, detailed data from a large study showed on Thursday.

Reporting by Natalie Grover in London; Editing by Richard Chang